These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35506283)

  • 1. Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET/CT imaging.
    Kou Y; Jiang X; Yao Y; Shen J; Jiang X; Chen S; Lu H; Wang X; Zhao M; Xiao D; Shen T; Zhang W; Cheng Z
    Nucl Med Commun; 2022 Jul; 43(7):847-854. PubMed ID: 35506283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of [
    Qiao K; Qin X; Fu S; Ren J; Jia J; Hu X; Tao Y; Yuan S; Wei Y
    Eur Radiol; 2024 Mar; 34(3):1948-1959. PubMed ID: 37670186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Wei Y; Cheng K; Fu Z; Zheng J; Mu Z; Zhao C; Liu X; Wang S; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1671-1681. PubMed ID: 34870727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAPI-04 Uptake in Healthy Tissues of Cancer Patients in
    Gündoğan C; Güzel Y; Can C; Kaplan İ; Kömek H
    Contrast Media Mol Imaging; 2021; 2021():9750080. PubMed ID: 34887714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of
    Hou J; Long T; Yang N; Chen D; Zeng S; Zheng K; Liao G; Hu S
    Mol Imaging Biol; 2021 Dec; 23(6):827-835. PubMed ID: 34231107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
    Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Arslan E; Çermik TF; Ergül N
    Nucl Med Commun; 2023 Oct; 44(10):896-899. PubMed ID: 37450605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation and pilot clinical study of [
    Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 68 Ga-DOTA-FAPI-04 PET/CT for the differential diagnosis of solitary fibroma of pleura from other chest disease with low uptake of 18 F-FDG.
    Zhang A; Meng X; Zhou X; Wang S; Zhang Y; Li N
    Nucl Med Commun; 2022 Aug; 43(8):908-915. PubMed ID: 35551166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing Benign and Malignant Findings on [
    Dabir M; Novruzov E; Mattes-György K; Beu M; Dendl K; Antke C; Koerber SA; Röhrich M; Kratochwil C; Debus J; Haberkorn U; Giesel FL
    Mol Imaging Biol; 2023 Apr; 25(2):324-333. PubMed ID: 35997853
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Qin C; Shao F; Gai Y; Liu Q; Ruan W; Liu F; Hu F; Lan X
    J Nucl Med; 2022 Jan; 63(1):81-88. PubMed ID: 33863819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased uptake of
    Qin C; Song Y; Liu X; Gai Y; Liu Q; Ruan W; Liu F; Hu F; Lan X
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):709-720. PubMed ID: 34241652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical translational evaluation of Al
    Wang S; Zhou X; Xu X; Ding J; Liu S; Hou X; Li N; Zhu H; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4259-4271. PubMed ID: 34165601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAP imaging in rare cancer entities-first clinical experience in a broad spectrum of malignancies.
    Dendl K; Finck R; Giesel FL; Kratochwil C; Lindner T; Mier W; Cardinale J; Kesch C; Röhrich M; Rathke H; Gampp H; Ristau J; Adeberg S; Jäger D; Debus J; Haberkorn U; Koerber SA
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):721-731. PubMed ID: 34342669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Mu X; Huang X; Jiang Z; Li M; Jia L; Lv Z; Fu W; Mao J
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1205-1215. PubMed ID: 36495325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.